Stage IV Cutaneous Melanoma
Also known as: Stage 4 Cutaneous Melanoma / Clinical Stage IV Cutaneous Melanoma / Cutaneous Melanoma, Stage IV
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18396 | IFx-Hu2.0 | 0 | Completed | 1 |
| DB12565 | Abexinostat | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB14865 | Human interleukin-2 | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB15389 | Teceleukin | 1 | Recruiting | 1 |
| DB00945 | Acetylsalicylic acid | 2 | Completed | 1 |
| DB11791 | Capmatinib | 2 | Terminated | 1 |
| DB09063 | Ceritinib | 2 | Terminated | 1 |
| DB11986 | Entrectinib | 2 | Terminated | 1 |
| DB06205 | Hyaluronidase (human recombinant) | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| DB08896 | Regorafenib | 2 | Terminated | 1 |
| DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
| DB18396 | IFx-Hu2.0 | Not Available | Available | 1 |